Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy

Journal of Infectious Diseases

Volumn 184, Issue 6, 2001, Pages 707-712

  Weinberg, A ^a   Wohl, D A ^a   Barrett, R J ^a   Van der Horst, C ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2;

ADULT; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INTERFERON PRODUCTION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HIV INFECTIONS; HIV SERONEGATIVITY; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; REFERENCE VALUES; REGRESSION ANALYSIS; T-LYMPHOCYTES;

EID: 0035884694     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/322859     Document Type: Article

References (39)

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
2. Cytomegalovirus retinitis in advanced HIV-infected patients treated with protease inhibitors: Incidence and outcome over 2 years
3. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: The Swiss HIV Cohort Study
4. Long lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients
5. Therapeutic effect of combination antiretroviral therapy on cytomegalovirus retinitis
6. Discontinuing anti-cytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy
7. Discontinuation of anticytomegalovirus therapy in patients with HIV infections and cytomegalovirus retinitis
8. Lack of reactivation of cytomegalovirus retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy
9. Natural history and outcome of new AIDS related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy
10. Immune recovery vitritis associated with inactive CMV retinitis: A new syndrome
11. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis
12. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy
13. CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy
14. Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution
15. + T-cell responses in HIV-1-infected subjects with relapsing CMV retinitis following successful highly active antiretroviral therapy
16. + T lymphocyte immune function in long-term survivors of CMV retinitis (CMVR) receiving HAART
17. Effect of shipment, storage, anticoagulant and cell separation on lymphoproliferative responses in HIV-infected patients
18. + T cells
19. Viability and functional activity of cryopreserved mononuclear cells
20. Limiting dilution analysis
21. + T cell frequencies by flow cytometry: Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency
22. +T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1
23. From naive to memory T cells
24. Two distinct stages in the transition from naive CD4 T cells to effectors, early antigen-dependent and late cytokine-driven expansion and differentiation
25. Homeostasis and self-tolerance in the immune system: Turning lymphocytes off
26. Cytotoxic T lymphocytes, chemokines and antiviral immunity
27. Direct visualization of cytokine-producing recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients
28. HO Cells
29. In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: Effects of interleukin (IL)-I2 and anti-IL-10
30. Interleukin-12 enhancement of antigen-specific lymphocyte proliferation correlates with stage of human immunodeficiency virus infection
31. Human immunodeficiency virus infection alters antigen-induced cytokine responses in patients with active mycobacterial diseases
32. Production of interleukins in human immunodeficiency virus-l-replicating lymph nodes
33. Elevated IFN-γ and decreased IL-2 gene expression are associated with HIV infection
34. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: Results of AIDS Clinical Trials Group Protocol 315
35. + T lymphocytes with changes in viral load
36. + lymphocyte activity
37. T cell-tropic HIV gpl20 mediates CD4 and CD8 cell chemotaxis through CXCR4 independent of CD4: Implications for HIV pathogenesis
38. Kinetics of the changes of lymphocyte subsets defined by cytokine production at single cell level during highly active antiretroviral therapy for HIV-1 infection
39. Pathogenesis of CMV immune recovery uveitis